{"id":2657,"date":"2019-02-05T23:24:07","date_gmt":"2019-02-05T23:24:07","guid":{"rendered":"https:\/\/sites.austincc.edu\/incubator\/?p=2657"},"modified":"2020-01-29T23:28:20","modified_gmt":"2020-01-29T23:28:20","slug":"lung-therapeutics-announces-new-chief-financial-officer","status":"publish","type":"post","link":"https:\/\/sites.austincc.edu\/incubator\/lung-therapeutics-announces-new-chief-financial-officer\/","title":{"rendered":"Lung Therapeutics Announces New Chief Financial Officer"},"content":{"rendered":"<p>[et_pb_section bb_built=&#8221;1&#8243;][et_pb_row][et_pb_column type=&#8221;2_3&#8243;][et_pb_text _builder_version=&#8221;3.17.2&#8243;]<\/p>\n<p>&#8216;Lung Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary indications, announced today the hiring of Charles T. Garner as Chief Financial Officer and the appointment of R.A. Session, II, to the company\u2019s Board of Directors.&#8217;<\/p>\n<p><a href=\"https:\/\/www.businesswire.com\/news\/home\/20190204005245\/en\/Lung-Therapeutics-Announces-New-Chief-Financial-Officer\" target=\"_blank\" rel=\"noopener\"><strong>Lung Therapeutics, Inc. Announces New Chief Financial Officer and Board Member<\/strong><\/a><br \/>\nSource: Business Wire<\/p>\n<p>Read the full article <a href=\"https:\/\/www.businesswire.com\/news\/home\/20190204005245\/en\/Lung-Therapeutics-Announces-New-Chief-Financial-Officer\" target=\"_blank\" rel=\"noopener\">HERE<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243;][et_pb_image _builder_version=&#8221;3.17.2&#8243; src=&#8221;https:\/\/sites.austincc.edu\/incubator\/wp-content\/uploads\/sites\/154\/2017\/12\/LungTX.jpg&#8221; url=&#8221;http:\/\/lungtx.com\/&#8221; url_new_window=&#8221;on&#8221; \/][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p><div class=\"et_pb_row et_pb_row_0 et_pb_row_empty\">\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div> &#8216;Lung Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary indications, announced today the hiring of Charles T. Garner as Chief Financial Officer and the appointment of R.A. Session, II, to the company\u2019s Board of Directors.&#8217; Lung Therapeutics, Inc. Announces New Chief Financial Officer and Board Member Source: Business Wire [&hellip;]<\/p>\n","protected":false},"author":4192,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1],"tags":[74],"class_list":["post-2657","post","type-post","status-publish","format-standard","hentry","category-press-and-recognition","tag-member-companies"],"acf":{"featured_banner":null},"_links":{"self":[{"href":"https:\/\/sites.austincc.edu\/incubator\/wp-json\/wp\/v2\/posts\/2657","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.austincc.edu\/incubator\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sites.austincc.edu\/incubator\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sites.austincc.edu\/incubator\/wp-json\/wp\/v2\/users\/4192"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.austincc.edu\/incubator\/wp-json\/wp\/v2\/comments?post=2657"}],"version-history":[{"count":0,"href":"https:\/\/sites.austincc.edu\/incubator\/wp-json\/wp\/v2\/posts\/2657\/revisions"}],"wp:attachment":[{"href":"https:\/\/sites.austincc.edu\/incubator\/wp-json\/wp\/v2\/media?parent=2657"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sites.austincc.edu\/incubator\/wp-json\/wp\/v2\/categories?post=2657"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sites.austincc.edu\/incubator\/wp-json\/wp\/v2\/tags?post=2657"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}